News & Updates

In patients with multivessel coronary artery disease, the risk of any-cause death, myocardial infarction (MI), or target vessel revascularization (TVR) did not vary according to whether patients underwent percutaneous coronary intervention (PCI) with everolimus-eluting stents (EES) or coronary artery bypass graft (CABG), extended follow-up of the BEST* trial showed.

A few patients in the intensive care unit (ICU) have registered a fever >38.5 °C while on dexmedetomidine therapy, reports a recent study.

A nonrestrictive fluoroquinolone reduction initiative at an urban teaching hospital has substantially lessened the use of this drug, which is associated with decreased antibiotic resistance in Staphylococcus aureus and Pseudomonas aeruginosa, a study has shown.

The use of fluocinolone acetonide improves visual outcomes and disease control in patients with diabetic macular edema (DME), as measured by a significant reduction in annual treatment burden, according to a study.

The antidepressant reboxetine demonstrates therapeutic potential in patients with obstructive sleep apnoea (OSA), with a recent study showing that the drug helps lower disease severity.

Renal transplant patients require a 20-percent reduction in tacrolimus (TAC) total daily dose (TDD) when used in tandem with low-dose fluconazole (LDF) to achieve therapeutic levels, suggests a study.

Use of fluoroquinolones for the treatment of pneumonia or urinary tract infection (UTI) does not appear to markedly increase the risk of hospital admission or emergency department visits due to suicidality compared with azithromycin or combined trimethoprim and sulfamethoxazole, a study has shown.